| Stage | NVDA | % of rev | SPCX | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $96.2B | 100.00% | $14.6B | 100.00% | NVDA ×6.60 |
| Gross profit | $72.1B | 74.98% | $9.1B | 62.42% | NVDA +12.6pp |
| Operating income | $63.7B | 66.24% | $2.8B | 19.15% | NVDA +47.1pp |
| Pre-tax income | $71.5B | 74.32% | $4.0B | 27.54% | NVDA +46.8pp |
| Net income | $59.7B | 62.03% | $4.4B | 30.22% | NVDA +31.8pp |
| Stage | NVDA | SPCX | Gap · A − B |
|---|---|---|---|
| Revenue | $96.2B100.00% | $14.6B100.00% | NVDA ×6.60 |
| Gross profit | 74.98%$72.1B | 62.42%$9.1B | NVDA +12.6pp |
| Operating income | 66.24%$63.7B | 19.15%$2.8B | NVDA +47.1pp |
| Pre-tax income | 74.32%$71.5B | 27.54%$4.0B | NVDA +46.8pp |
| Net income |
| 62.03%$59.7B |
| 30.22%$4.4B |
| NVDA +31.8pp |
No shared counterparties.